DK43890A - Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse - Google Patents

Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse Download PDF

Info

Publication number
DK43890A
DK43890A DK043890A DK43890A DK43890A DK 43890 A DK43890 A DK 43890A DK 043890 A DK043890 A DK 043890A DK 43890 A DK43890 A DK 43890A DK 43890 A DK43890 A DK 43890A
Authority
DK
Denmark
Prior art keywords
nucleic acid
vectors
cells containing
produced products
peptides
Prior art date
Application number
DK043890A
Other languages
English (en)
Other versions
DK43890D0 (da
Inventor
Raymond Alan Brian Ezekowitz
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22206319&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK43890(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of DK43890A publication Critical patent/DK43890A/da
Publication of DK43890D0 publication Critical patent/DK43890D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK043890A 1987-08-20 1990-02-19 Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse DK43890D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8762887A 1987-08-20 1987-08-20
PCT/US1988/002591 WO1989001519A1 (en) 1987-08-20 1988-08-05 Human mannose binding protein

Publications (2)

Publication Number Publication Date
DK43890A true DK43890A (da) 1990-02-19
DK43890D0 DK43890D0 (da) 1990-02-19

Family

ID=22206319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK043890A DK43890D0 (da) 1987-08-20 1990-02-19 Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse

Country Status (7)

Country Link
EP (1) EP0375736B1 (da)
JP (1) JP2868777B2 (da)
AT (1) ATE165980T1 (da)
DE (1) DE3856180T2 (da)
DK (1) DK43890D0 (da)
FI (1) FI900808A0 (da)
WO (1) WO1989001519A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006010A1 (en) * 1989-10-11 1991-05-02 Institute Of Child Health Diagnostic procedure
GB9023907D0 (en) * 1990-11-02 1990-12-12 Mallucci Livio Cell growth inhibitors
JPH06501620A (ja) * 1990-11-06 1994-02-24 ザ・チルドレンズ・メディカル・センター・コーポレイション 可溶性マンノース受容体ペプチド
CA2056118A1 (en) * 1990-12-24 1992-06-25 Kendra B. Eager Monoclonal antibodies which bind mannose binding protein
WO1993002709A1 (en) * 1991-07-31 1993-02-18 Microcarb Inc. Receptor conjugates for targeting drugs and other agents
EP0842297A1 (en) 1995-07-27 1998-05-20 IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY & MEDICINE Methods of predicting the outcome of infection
EP1008351B1 (en) 1997-08-21 2006-11-15 Takara Bio Inc. Carcinostatic agents
US7049099B2 (en) 1998-01-23 2006-05-23 Fuso Pharmaceutical Industries, Ltd. Recombinant human mannan-binding proteins and producing method of the same
JPH11206378A (ja) 1998-01-23 1999-08-03 Fuso Pharmaceutical Industries Ltd 組換えヒトマンナン結合タンパク質およびその製造方法
JP3878737B2 (ja) 1998-01-23 2007-02-07 扶桑薬品工業株式会社 新規コレクチン
US6429192B1 (en) * 1998-06-10 2002-08-06 Statens Serum Institut Purification process for production of mannan-binding lectin and an MBL medicinal product
US7273925B1 (en) 1998-12-15 2007-09-25 Brigham And Women's Hospital, Inc. Methods and products for regulating lectin complement pathway associated complement activation
JP2002532079A (ja) * 1998-12-15 2002-10-02 ザ ブライハム アンド ウイミンズ ホスピタル， インコーポレイテッド 補体活性化に関連するレクチン補体経路を調節するための方法および産物
CN1715296A (zh) * 1999-05-14 2006-01-04 斯蒂芬·蒂尔 重组人甘露聚糖结合型凝集素
DK1181038T3 (da) 1999-05-14 2004-08-09 Steffen Thiel Hidtil ukendte indikationer af mannanbindende lectin (MBL) til behandling af immunkompromitterede individer
KR100514521B1 (ko) 2000-02-14 2005-09-14 후소 야쿠힝 고교 가부시끼가이샤 신규 스캐빈저 리셉터
US20030158382A1 (en) 2000-04-21 2003-08-21 Nobutaka Wakamiya Novel collectins
WO2002006460A2 (en) * 2000-07-13 2002-01-24 Jens Christian Jensenius Masp-2, a complement-fixing enzyme, and uses for it
EP1186299A1 (en) * 2000-09-12 2002-03-13 Universitair Medisch Centrum Utrecht The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system
WO2007085057A1 (en) * 2006-01-25 2007-08-02 The Council Of The Queensland Institute Of Medical Research A medical protocol
US8524453B2 (en) 2006-02-10 2013-09-03 The Brigham And Woman's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
CA2787376A1 (en) 2010-01-19 2011-07-28 President And Fellows Of Harvard College Engineered opsonin for pathogen detection and treatment
EP3081937B1 (en) 2011-07-18 2019-11-13 President and Fellows of Harvard College Engineered microbe-targeting molecules and uses thereof
CA2865744A1 (en) 2012-02-29 2013-09-06 President And Fellows Of Harvard College Rapid antibiotic susceptibility testing
WO2014144325A1 (en) 2013-03-15 2014-09-18 President And Fellows Of Harvard College Methods and compositions for improving detection and/or capture of a target entity
EP3010522B1 (en) 2013-05-21 2021-01-20 President and Fellows of Harvard College Engineered heme-binding compositions and uses thereof
WO2015095604A2 (en) 2013-12-18 2015-06-25 President And Fellows Of Harvard College Methods and assays relating to circulating tumor cells
CN108289928A (zh) 2015-08-06 2018-07-17 哈佛大学校长及研究员协会 改进的微生物-结合分子和其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3369466D1 (en) * 1982-05-12 1987-03-05 Harvard College Fused genes encoding hybrid proteins, cloning vectors containing them and the use thereof

Also Published As

Publication number Publication date
EP0375736B1 (en) 1998-05-13
FI900808A0 (fi) 1990-02-19
ATE165980T1 (de) 1998-05-15
WO1989001519A1 (en) 1989-02-23
JPH02504581A (ja) 1990-12-27
DE3856180D1 (de) 1998-06-18
JP2868777B2 (ja) 1999-03-10
EP0375736A1 (en) 1990-07-04
DK43890D0 (da) 1990-02-19
DE3856180T2 (de) 1998-09-03

Similar Documents

Publication Publication Date Title
DK43890A (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
DK382786A (da) Overfladeaktivt rekombinant-alveolarprotein
HUP0003533A2 (hu) Interleukin-18-at kötő fehérjék, előállításuk és alkalmazásuk
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
DE68929551D1 (de) Menschliche DNase
DE3683482D1 (de) Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression.
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
DE69634912D1 (de) Intrazellulare domäne des her-2/neu proteins, für die prevention oder behandlung von bösartigen tumoren
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
DE68925226D1 (de) Monoklonale Antikörper
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
DK235687A (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
FI913818A0 (fi) Nytt trombolytiskt aemne.
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
SE9002212D0 (sv) Igg binding protein
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
ATE116368T1 (de) Vektoren und verbindungen zur expression von zymogen-formen von menschlichem protein c.
EP0315081A3 (en) Anti-coagulating protein pp4-x, its preparation and use
DE3765916D1 (de) Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde.
NO900745L (no) Humant mannose-bindende protein.
DE59611330D1 (de) Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen
NO880825D0 (no) Dietetisk styrke- og helbredelsesmiddel for behandling av den helhetlige organismen hos mennesker og dyr.
DE59805440D1 (de) Verwendung von lbp zur sepsistherapie
DK694287A (da) Overfladeaktivt rekombinant-alveolaerprotein

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment